| 14.55 Net Asset Value | -0.21% 1 Day | +5.66% Year-to-Date | Overall Morningstar Rating |
| Foreign large value Style or Category | No Load Sales Expenses | 0.86% Expense Ratio | Average Morningstar Risk Rating™ |
| 1 month | +4.45% | 3 years | +8.08% | |
| 3 months | +0.95% | 5 years | +7.96% | |
| 1 year | -1.35% | Since inception | +5.36% |
| TRIGX | Category | |
|---|---|---|
| Performance 5-yr return | +7.96% | +4.27% |
| Expense ratio | 0.86% | 1.33% |
| Risk 5 year sharpe ratio | 0.46 | 0.39 |
| Net assets | $10.6B | $1.4B |
| Average market cap | $20.4B | $32.2B |
| Average P/E | 15.1 | 14.5 |
| Portfolio turnover | 45% | 45% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | T. Rowe Price |
| Fund manager & tenure | Jonathan Matthews / 4 Years |
| Minimal initial investment | $2,500.00 |
| Minimum IRA investment | $1,000.00 |
| International stock | 90.84% |
| Cash | 5.70% |
| U.S. stock | 1.60% |
| Other | 1.47% |
| Fixed income | 0.39% |
| Financial service | 24.22% |
| Industrial materials | 22.65% |
| Consumer goods | 13.81% |
| Telecommunication | 9.81% |
| Energy | 9.40% |
| RDSB Royal Dutch Shell | 2.63% |
| -- | 2.61% |
| -- | 1.83% |
| -- | 1.64% |
| BCS Barclays | 1.56% |
| TEVA Teva Pharmaceutical | 1.49% |
| -- | 1.49% |
| -- | 1.47% |
| -- | 1.44% |
| -- | 1.44% |
